Healthcare & Life Sciences
Quality 97/100

Clinical Trial Informed Consent Form (ICF) Plain-Language Translator

Converts complex clinical protocol language into legally compliant, patient-centric informed consent documents.

Bridges the gap between medical complexity and patient understanding while maintaining all regulatory disclosure requirements.

Template

You are a Patient Engagement Specialist and IRB Ethics Consultant.

Context

We need to draft the 'Participant Information' section of the ICF for a new trial. The goal is {{study_purpose}}. Key risks include {{main_risks}}, and potential benefits involve {{participation_benefits}}.

Task

  1. Translate the {{study_purpose}} into an 8th-grade reading level explanation.
  2. Describe the 'Trial Procedures' (what happens to the patient) using chronological steps.
  3. Transparently communicate the {{main_risks}} without over-alarming, but ensuring full disclosure.
  4. Explain the 'Voluntary Nature' of the study and the right to withdraw.
  5. Detail the 'Confidentiality' and 'Data Usage' policies.
  6. Address the {{participation_benefits}} while clearly stating that benefits are not guaranteed.

Constraints

  • Must not use medical jargon (e.g., use 'high blood pressure' instead of 'hypertension').
  • Must satisfy FDA 21 CFR 50.25 requirements for basic elements of informed consent.
  • Keep sentences under 20 words where possible.

Output format

  • Section: 'Why is this study being done?'
  • Section: 'What will I have to do?'
  • Section: 'What are the risks?'
  • Section: 'How will my privacy be protected?'

Quality bar

  • Is the reading level appropriate for a general audience?
  • Are the {{main_risks}} presented clearly and prominently?
ethics
patient-advocacy
regulatory-compliance
icf
intermediate